Release Date: 03/03/14 09:18 Summary: Brookfield Capital Management Limited Board Changes Price Sensitive: No Download Document 141.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%